The
prosthetic joint infection market has been growing rapidly owing to the
increasing number of joint replacement surgeries performed globally each year.
Prosthetic joint infections occur when bacteria or other microbes enter the
surgical site during or after a hip or knee replacement surgery. The implants
used for joint replacements, such as knees, hips, and shoulders, can get
infected by some types of bacteria. Symptoms of prosthetic joint infection
include pain, swelling, drainage, redness or warmth around the area of the
joint replacement. There is an increasing need for effective treatment options
and prevention measures for prosthetic joint infections, as these can cause
pain, loss of mobility and may even require another surgery for implant removal
and antibiotic treatment if not addressed promptly. The Global Prosthetic
Joint Infection Market is estimated to be valued at US$ 64.2 Million in
2024 and is expected to exhibit a CAGR of 5.2% over the forecast period
2024-2031.
Key Takeaways
Key players operating in the prosthetic joint infection market are Zimmer
Biomet, Smith & Nephew, DePuy Synthes (Johnson & Johnson), Stryker, 3M
Healthcare. Zimmer Biomet and Stryker collectively hold over 45% of the market
share owing to their wide product portfolios and global presence.
Some key opportunities in the market include expanding into developing
countries, launch of advanced diagnostic tests with short turn-around-times and
development of novel antibiofilm coatings for implants. The increasing implantation
volumes in Asia Pacific and Latin American countries will drive significant
growth.
Globally, the incidence of prosthetic joint infections is expected to double by
2030 owing to rising geriatric population globally. Key players are expanding their
presence in Asia Pacific and Latin American countries to gain early mover
advantages. Partnerships with local distributors are helping penetrated
untapped markets.
Market Drivers
Rising geriatric population worldwide susceptible to osteoarthritis and
other joint conditions driving joint replacement volumes. According to the UN,
over next 30 years 2000 Mn people will be aged over 60 worldwide creating high
demand.
Market Restrains
High cost of treatment for prosthetic joint infections adds a significant
burden on joint replacement patients and healthcare systems. PJI treatment
often requires a two-stage process of implant removal followed by antibiotic
treatment and new implantation which is very expensive.
Segment Analysis
The prosthetic joint infection market is dominated by
the hip and knee implant sub-segment. Hip and knee replacement surgeries are
commonly performed orthopedic procedures globally due to degenerative joint
diseases like osteoarthritis and trauma or injury related joint damages. According
to the Centers for Disease Control and Prevention (CDC), more than 7 million
Americans have received hip or knee replacements. The increasing volume of such
joint replacement surgeries directly translates to higher incidence of
post-surgical prosthetic joint infections. Hence, the hip and knee implant
sub-segment accounts for a major share of the overall prosthetic joint
infection treatment market.
Global Analysis
North America is currently the fastest growing as well as the largest
regional market for prosthetic joint infection treatment. This is mainly due to
rising geriatric population, which are at an elevated risk of arthroplasty
procedures. Additionally, well-established healthcare infrastructure and
skilled workforce in countries like the US and Canada enable timely diagnosis
and management of prosthetic joint infections. Moreover, growing public
awareness about hygiene maintenance during hospital visits and joint
replacement surgeries aid in region's market dominance.
However,
Asia Pacific region is projected to depict the highest growth over the forecast
period owing to improving access to advanced orthopedic treatments in major
countries like India, China and Japan.
Get more insights on this topic : https://justpaste.it/98uch
What
Are The Key Data Covered In This Prosthetic Joint Infection Market Report?
:- Market
CAGR throughout the predicted period
:- Comprehensive
information on the aspects that will drive the Prosthetic Joint Infection 's
growth between 2024 and 2031.
:- Accurate
calculation of the size of the Prosthetic Joint Infection and its contribution to the market, with
emphasis on the parent market
:- Realistic
forecasts of future trends and changes in consumer behaviour
:- Prosthetic
Joint Infection Industry Growth in North
America, APAC, Europe, South America, the Middle East, and Africa
:- A
complete examination of the market's competitive landscape, as well as
extensive information on vendors
:- Detailed
examination of the factors that will impede the expansion of Prosthetic Joint
Infection vendors
About Author:
Ravina Pandya, Content Writer, has a strong foothold
in the market research industry. She specializes in writing well-researched
articles from different industries, including food and beverages, information
and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
*Note:
1.
Source: Coherent Market Insights, Public sources, Desk research
2.
We have leveraged AI tools to mine information and compile it
Comments
Post a Comment